Posted August 2, 2018 by mildasmoser
Aprezo (otezla) an inhibitor of phosphodiesterase 4 (PDE4), is indicated for the treatment of active psoriatic arthritis and severe plaque psoriasis from Glenmark.
Contact Email | [email protected] |
Issued By | thomas shaw |
Website | Apremilast price |
Business Address | Los Angels |
Country | United States |
Categories | Business |
Tags | apremilast price |
Last Updated | August 2, 2018 |